Abbott Laboratories (ABT.N) said it would buy Alere Inc (ALR.N) for $5.8 billion to become a leader in point-of-care testing, a fast-growing market as physicians increasingly adopt rapid tests that speed up treatment...
Insulin drug maker Mannkind explores sale
Mannkind Corp (MNKD.O), the U.S. maker of inhaled insulin drug Afrezza, is exploring strategic options, including the sale of itself, people familiar with the matter said on Tuesday. Earlier this month, France’s...
Cipla completes stake sale in Biomab Holding.
Drug major Cipla today announced completion of selling its entire holding in Hong Kong-based Biomab Holding to Biomab Brilliant for $ 2.5 million. The company on January 22, 2016 completed the transfer formalities in...
Torrent, Dr Reddy’s, Aurobindo, Cipla, Lupin in race to buy Sagent.
At least five Indian drug companies — Torrent Pharmaceuticals, Dr Reddy’s Laboratories, Aurobindo Pharma, Cipla and Lupin — are in initial discussions to bid for Sagent Pharmaceuticals, a Nasdaq-listed...
Cipla gets CCI nod for investment by FIL Capital.
Drug major Cipla today said it has received approval from competition watchdog CCI over the proposed investment by Mauritius-based FIL Capital Investments in its consumer healthcare business vertical. The Competition...
YK Hamied to increase stake in Cipla to over 20 per cent.
In a move aimed at realignment of family shareholding, CiplaBSE -0.03 % patriarch YK Hamied plans to increase his holding to over 20 per cent by acquiring over 5 per cent additional stake in the homegrown drug major...
Strides Shasun gets CCI nod to buy 7 brands of Johnson and Johnson.
Pharma Company Strides Shasun today got competition watchdog CCI’s approval to acquire seven brands from consumer healthcare firm Johnson and Johnson. Through the deal, Strides will buy Johnson and Johnson’s...
Emcure Pharmaceuticals acquires Canadian company and its marketing arm Marcan
Emcure Pharmaceuticals, a Pune-based drug maker, has acquired Canada’s International Pharmaceutical Generics Ltd. and its marketing arm Marcan Pharmaceuticals in a deal that’s expected to bolster the Indian...
Alembic Pharma arm ties up with Novartis for drug development
NEW DELHI: Alembic Pharmaceuticals group firm Rhizen Pharmaceuticals SA has entered into an exclusive worldwide license agreement with NovartisBSE 1.73 % for the development and commercialisation of a lead compound that...
Teva to Sell $6.75 Billion in Stock to Buy Allergan Unit, Rimsa
Teva Pharmaceutical Industries Ltd. is selling about $6.75 billion worth of ordinary and preferred shares to fund its takeover of Allergan Plc’s generic-drug business as well as other acquisition-related expenses. The...
Merck plans to sell its allergy business unit to cut debt: Bloomberg
German drugs and chemicals maker Merck KGaA (MRCG.DE) is planning to sell its allergy business, Allergopharma, Bloomberg reported, citing sources. The sale, which could fetch about 600 million euros ($636.42 million)...
OrbiMed Invests In Online Pharmacy Startup NetMeds Marketplace
Online pharma aggregator Netmeds.com, has raised about R325 Cr ($50 Mn) from healthcare focused mid-stage PE firm OrbiMed. The round also saw the participation from Pradeep Dadha Group and boutique investment bank MAPE...
